Eclipse Surgical Tech (ESTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eclipse Surgical Tech (ESTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark J Trudeau who wrote (18)	3/4/1998 3:20:00 PM
From: Paul Tran	Read Replies (1) of 103

In the previous SPNC link, the news said: -- Transmyocardial revascularization (TMR). This experimental procedure uses lasers to create small holes in oxygen-starved heart muscles to stimulate growth of new blood vessels in patients with limited treatment options. Through a strategic partnership, United States Surgical Corporation will purchase Spectranetics laser systems and disposables for use in TMR procedures. and in ESTI link, the news said: Positive Clinical Results From Eclipse TMR Plus Bypass Trial Reported To FDA SUNNYVALE, Calif., March 4 /PRNewswire/ -- Eclipse Surgical Technologies,Inc. (Nasdaq: ESTI) announced today that a blinded, independent Data and Safety Monitoring Committee reviewed the results of its clinical trial studying Transmyocardial Revascularization (TMR) performed in conjunction with coronary artery bypass graft surgery and concluded that no additional patients need to be enrolled in the study. newsalert.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next